Article references (54 references )

  1. Crum C P, Quick C M, Laury A R, Peters III W A, Hirsch M S. Gynecologic and Obstetric Pathology High-Yield Pathology, Philadelphia. Elsevier health services. 2016;235-335.

  2. Atara N. Cervical Cancer in Sub Sahara Africa. InTech. 2012;51-74. Google Scholar

  3. Witkiewicz A K, Wright T C, Ferenczy A, Ronnett B M, Kurman R J. Carcinoma and other tumours of the Cervix, Blaustein's Pathology of the Female Genital Tract. Springer. 2011;254-295. Google Scholar

  4. Mohar A, Frias-Mendivil M. Epidemiology of Cervical Cancer. Informa Healthcare. 2000;18(6):584-590. PubMed | Google Scholar

  5. Bruni L, Barrionuevo-Rosas L, Albero G, Aldea M, Serrano B, Valencia S et al. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Nigeria. Summary Report 2015.

  6. Kyari O, Nggada H, Mairiga A. Malignant tumours of female genital tract in North Eastern Nigeria. East Africa Medical Journal. 2004;81(3):142-145. PubMed | Google Scholar

  7. Bosch F X, Manos M M, Munoz N, Sherman M, Jansen A M, Peto J et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective, International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995;87(11):796-802. PubMed | Google Scholar

  8. Clifford G M, Smith J S, Plummer M, Munoz N, Franceschi S. Human Papillomavirus types in Invasive Cervical Cancer worldwide: a meta-analysis. Br J Cancer. 2003 Jan 13;88(1):63-73. PubMed | Google Scholar

  9. Shuyama K, Castillo A, Aguayo F, Sun Q, Khan N, Koriyama C et al. Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China. British Journal of Cancer. 2007;96(10):1554-1559. PubMed | Google Scholar

  10. Bosch F X, Munoz N, de Sanjose S, Izarzugaza I, Gili M, Viladiu P et al. Risk factors for cervical cancer in Colombia and Spain. International Journal of Cancer. 1992;52(5):750-758. PubMed | Google Scholar

  11. Hadzisejdic I, Sinat M, Bosak A, Krasevic M, Grahovac B. Prevalence of Human Papillomavirus Genotypes in Cervical Cancer and Precursor Lesions. Coll Antropol. 2006;30(4):879-883. PubMed | Google Scholar

  12. Castellsague X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecologic Oncology. 2008 Sep;110(3 Suppl 2):S4-7. PubMed | Google Scholar

  13. Anna-Barbara M. Natural History of HPV Infection in Adolescents and Relationship to Cervical Cancer, Molecular Pathology of Gynecologic Cancer, Totowa, New Jersey, Humana Press. Springer. 2007;103-112. Google Scholar

  14. Bekele A, Baay M, Mekonnen Z, Suleman S, Chatterjee S. Human papillomavirus type distribution among women with cervical pathology- a study over 4 years at Jimma Hospital, southwest Ethiopia. Tropical Medicine and International Health. 2010;15(8):890-893. PubMed | Google Scholar

  15. Stamenković M, Knezević A, Kuzmanović I, Karalić D, Jovanović T. Distribution of Human Papilloma Virus Genotypes in Cervical Cancer Tissues. Arch Biol Sci. 2014;66(2):573-577. Google Scholar

  16. Hopenhayn C, Christian A, Christian W J, Watson M, Unger E R, Lynch C F et al. Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction. J Low Genit Tract Dis. 2014;18(2):182-189. PubMed | Google Scholar

  17. Munagala R, M Donŕ M G, Rai S N, Jenson A B, Bala N, Ghim S J et al. Significance of multiple HPV infection in cervical cancer patients and its impact on treatment response. International Journal of Oncology. 2009;34(1):263-271. PubMed | Google Scholar

  18. Chinchai T, Chansaenraj J, Swangvaree S, Junyangdikul P, Poovorawan Y. Prevalence of human papillomavirus genotypes in cervical cancer. Int J Gynecol Cancer. 2012;22(6):1063-1068. PubMed | Google Scholar

  19. Howitt B E, Herfs M, Tomoka T, Kamiza S, Gheit T, Tommasino M et al. Comprehensive Human Papillomavirus Genotyping in Cervical Squamous Cell Carcinomas and Its Relevance to Cervical Cancer Prevention in Malawian Women. J Glob Oncol. 2017;3(3):227-234. PubMed | Google Scholar

  20. Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T et al. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa. Int J Cancer. 2014; 134(6):1389-1398. PubMed | Google Scholar

  21. Okolo C, Franceschi S, Adewole I, Thomas J O, Follen M, Snijders P J F et al. Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria. Infectious Agents and Cancer. 2010;5(1):24. PubMed | Google Scholar

  22. Dybikowska A, Licznerski P, Podhajska A. HPV detection in cervical cancer patients in northern Poland. Oncology Reports. 2002;9(4):871-874. PubMed | Google Scholar

  23. Mahmoodi P, Motamedi H, Abad Shapouri M R S, Shehni M B, Kargar M. Molecular Detection and Typing of Human Papillomaviruses in Paraffin-Embedded Cervical Cancer and Pre-Cancer Tissue Specimens. Iran J Cancer Prev. 2016 Feb 22;9(1):e3752. PubMed | Google Scholar

  24. Eslami G, Golshani M, Rakhshan M, Fallah F, Goudarzi H, Afsoun T. PCR detection and high risk typing of human papillomavirus DNA in cervical cancer in Iranian women. Cancer Therapy. 2008;6:361-366.

  25. Awua A K, Sackey S T, Osei Y D, Asmah R H, Wiredu E K. Prevalence of human papillomavirus genotypes among women with cervical cancer in Ghana. Infectious Agents and Cancer. 2016 Jan 26;11:4. PubMed | Google Scholar

  26. Snijders P J F, Heideman D A M, Meijer C J L M. Methods for HPV detection in exfoliated cell and tissue specimens. APMIS. 2010 Jun;118(6-7):520-8. PubMed | Google Scholar

  27. Castro F A, Koshiol J, Quint W, Wheeler C M, Gillson M L,Vaughan L M et al. Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods. BMC Infectious Disease. 2015;15:544. PubMed | Google Scholar

  28. Chan P K S, Chan D P C, To K-F, Yu M Y, Cheung J L K, Cheng A F. Evaluation of extraction methods from paraffin wax embedded tissues for PCR amplification of human and viral DNA. J Clin Pathol. 2001;54(5):401-403. PubMed | Google Scholar

  29. Biedermann K, Dandachi N, Trattner M, Vogl G, Doppelmayr H, Moré E et al. Comparison of Real-Time PCR Signal-Amplified In-Situ Hybridization and Conventional PCR for Detection and Quantification of Human Papillomavirus in Archival Cervical Cancer Tissue. J Clin Microbiol. 2004;42(8):3758-3765. PubMed | Google Scholar

  30. Garland S M, Tabrizi S. Methods for HPV Detection: Polymerase Chain Reaction Assays, Emerging Issues on HPV Infections, From Science to Practice. Basel Karger. 2006;63-72. Google Scholar

  31. Szostek S, Klimek M, Zawilinska B, Rys J, Kopec J, Daszkiewicz E. Detection of human papillomavirus in cervical cell specimens by hybrid capture and PCR with different primers. Acta Biochimica Polonica. 2006;53(3):603-607. PubMed | Google Scholar

  32. Louie K S, de Sanjose S, Mayaud P. Epidemiology and prevention of human papillomavirus and cervical cancer in Sub-Saharan Africa: a comprehensive review. Tropical medicine and International Health. 2009;14(10):1287-1302. PubMed | Google Scholar

  33. Loya A, Serrano B, Rasheed F, Tous S, Hassan M, Clavero O et al. Human Papillomavirus Genotype Distribution in Invasive Cervical Cancer in Pakistan. Cancers (Basel). 2016 Jul 30;8(8). pii: E72. PubMed | Google Scholar

  34. Gómez D T, Santos J L. Human Papillomavirus Infection and Cervical Cancer: Pathogenesis and Epidemiology (Review). Communicating Current Research and Educational Topics and Trends in Applied Microbiology. 2007;680-688. Google Scholar

  35. Hassan M Z, Soleimanjahi Z M, Mahmoodi H, Mirshahabi H, Farhadi H et al. Detection of human papillomaviruses type 16 and 18 by PCR and RFLP in paraffin-embedded cervical cancer tissue specimens. Archives of Razi Institute. 2006;6(3):159-165. Google Scholar

  36. Elhag W I, Abba K A, Abdelmutalab F G, Hammad H E. Molecular Detection of Human Papillomavirus Type-16 DNA in Cervical Cancer Tissue Biopsies. Bahrain Med Bull. 2013;35(4):1-6. Google Scholar

  37. Soma M, Kamaraj S. Detection of Human Papillomavirus in Cervical Grading by Immunohistochemistry and Typing of HPV16 and 18 in High-Grade by Polymerase Chain Reaction. Journal of Laboratory Physicians. 2010;2(1):31-36. Google Scholar

  38. Senapati R, Senapati N N, Dwibedi B. Molecular mechanism of HPV mediated neoplastic progression. Infectious Agents and Cancer. 2016;11:59. PubMed | Google Scholar

  39. Zohoncon T M, Quedraogo T C, Brun L V S, Obiri-Yeboah D, Djigma W F, Kabibou S et al. Molecular Epidemiology of High-Risk Human Papillomavirus in High-Grade Cervical Intraepithelial Neoplasia and in Cervical Cancer in Parakou, Republic of Benin. Pakistan Journal of Biological Sciences. 2016;19(2):49-56. PubMed | Google Scholar

  40. Salazar K L, Zhou H S, Xu J, Peterson L E, Schwartz M R, Mody D R et al. Multiple Human Papillomavirus Infections and Their Impact on the Development of High-Risk Cervical Lesions. Acta Cytologica. 2015;59(5):391-398. PubMed | Google Scholar

  41. Genta M L N D, Martins T R, Lopez R V M, Sadalla J C, Mancusi de Carvalho J P, Baracat E C et al. Multiple HPV genotype infection impact on invasive cervical cancer presentation and survival. PLoS ONE. 2017;12(8):1-10. PubMed | Google Scholar

  42. Kim G, Park S, Wang H Y, Kim S, Park S, Yu K et al. Distribution of Oncogenic Human Papillomavirus Genotypes at High-Grade Cervical Lesions above CIN2 Grade with Histological Diagnosis. BSL. 2016;22(4):37-45. Google Scholar

  43. Karunaratne K, Ihalagama H, Rohitha S, Molijn A, Gopala K, Schmidt J E et al. Human Papillomavirus prevalence and type-distribution in women with cervical lesions: a cross-sectional study in Sri Lanka. BMC cancer. 2014;14:116. PubMed | Google Scholar

  44. Pista A, Ribeiro F. Single and Multiple human papillomavirus infections in cervical abnormalities in Portuguese women. Clinical Microbiology and Infection. 2011;17(6):941-946. PubMed | Google Scholar

  45. Chaturvedi A K, Katki H A, Hildesheim A, Rodriguez A C, Quint W, Schiffman M et al. Human Papillomavirus Infection with Multiple Types: Pattern of Coinfection and Risk of Cervical Disease. The Journal of Infectious Disease. 2011;203(7):910-920. PubMed | Google Scholar

  46. Baseman J G, Koutsky L A. The epidemiology of human papillomavirus infections. Journal of Clinical Virology. 2005 Mar;32 Suppl 1:S16-24. PubMed | Google Scholar

  47. Wang L, Wang P, Ren Y, Du J, Jiang J, Jia X et al. Prevalence of High-Risk Human Papillomavirus (HR-HPV) Genotypes and Multiple Infections in Cervical Abnormalities from Northern Xinjiang, China. PLoS ONE. 2016;11(8):e0160698. PubMed | Google Scholar

  48. Lopalco P L. Spotlight on the 9-valent HPV vaccine. Drug Des Devel Ther. 2017;11:35-44. PubMed | Google Scholar

  49. Yang DY, Bracken K. Update on the new 9-valent vaccine for human papillomavirus prevention. Can Fam Physician. 2016;62(5):399-402. PubMed | Google Scholar

  50. Ellenson L H, Pirog E C. The Female Genital Tract, In Kumar V, Abbas A K, Aster J C (Eds), Robbins and Cotran Pathologic Basis of Disease, 9th Ed Philadelphia. Elsevier Saunders. 2015;992-1041.

  51. Manga M M, Fowotade A, Abdullahi Y M, El-Nafaty A U, Adamu S, Bojude A D et al. Comparative Analysis of Cervical Human Papillomavirus DNA Testing and Cytological Findings among Women Presenting for "Pap" Smear in a Tertiary Health Centre in Northern Nigeria. International Journal of Tropical Disease & Health. 2016;13(2):1-8. Google Scholar

  52. Kolawole O, Ogah J, Alabi O, Suleiman M, Amuda O, Kolawole F. Utilization of Human Papillomavirus DNA Detection for Cervical Cancer Screening in Women Presenting with Abnormal Cytology in Lokoja, Nigeria. Jundishapur J Microbiol. 2015;8(10):e22620. PubMed | Google Scholar

  53. Wright T C, Stoler M H, Behrens C M, Sharma A, Zhang G, Wright T L et al. Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test. Gynecologic Oncology. 2015;136(2):189-197. PubMed | Google Scholar

  54. Huh W K, Ault K A, Chelmow D, Davey D D, Goulart R A, Garcia F A R et al. Use of Primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance. Gynecologic Oncology. 2015 Feb;136(2):178-82. PubMed | Google Scholar